Table 7.
Item | HCP | MCP (− 2, %) | LCP (− 4, %) | P 1 | P 2 | ||||
---|---|---|---|---|---|---|---|---|---|
10 EAAs | 10 EAAs | 10 EAAs | Lys, Met,Thr, Trp |
Lys, Met,Thr, Trp, Ile |
Lys, Met,Thr, Trp, Val |
Lys, Met,Thr, Trp, Ile, Val |
|||
0 h, mg/m 3 | |||||||||
Phase I 50, kg | 95.06 ± 17.13x | 65.05 ± 12.99xy | 33.06 ± 9.06y | 37.37 ± 7.13 | 29.43 ± 8.37 | 31.11 ± 13.76 | 37.36 ± 9.50 | 0.02 | 0.96 |
Phase II 75, kg | 23.43 ± 3.60x | 9.43 ± 1.99y | 8.65 ± 1.05y | 9.44 ± 1.15 | 9.86 ± 2.32 | 8.89 ± 2.33 | 9.25 ± 1.79 | < 0.01 | 0.89 |
Phase III 100, kg | 19.98 ± 4.39x | 8.45 ± 1.12y | 4.39 ± 0.61y | 4.12 ± 0.36 | 4.83 ± 0.63 | 4.01 ± 1.79 | 2.85 ± 0.58 | < 0.01 | 0.66 |
Phase IV 125, kg | 30.48 ± 8.43x | 15.26 ± 4.01xy | 7.25 ± 2.10y | 9.29 ± 1.82 | 5.51 ± 2.01 | 9.27 ± 1.39 | 10.76 ± 1.36 | 0.03 | 0.28 |
4 h, mg/m 3 | |||||||||
Phase I 50, kg | 275.44 ± 23.37x | 156.01 ± 26.53y | 75.51 ± 16.85z | 66.67 ± 9.44 | 66.53 ± 17.32 | 67.99 ± 15.99 | 78.09 ± 10.47 | < 0.01 | 0.96 |
Phase II 75, kg | 189.89 ± 28.81x | 62.94 ± 14.14y | 43.72 ± 5.79y | 54.17 ± 11.87 | 54.99 ± 13.27 | 49.06 ± 7.82 | 54.86 ± 11.74 | < 0.01 | 0.92 |
Phase III 100, kg | 118.81 ± 18.67x | 57.71 ± 6.59y | 32.39 ± 5.49y | 28.44 ± 4.08 | 28.13 ± 2.92 | 27.82 ± 4.64 | 33.25 ± 2.66 | < 0.01 | 0.81 |
Phase IV 125, kg | 154.60 ± 25.74x | 78.74 ± 6.93y | 42.71 ± 3.54y | 50.55 ± 7.87 | 44.93 ± 5.82 | 42.69 ± 3.92 | 47.52 ± 7.04 | < 0.01 | 0.86 |
P1 represented the P value of ANOVA among the HCP diet, MCPdiet and LCP diet with balancing 10 EAAs.
P2 represented the P value of ANOVA among different amino acid balanced patterns of the LCP diets groups.
x,y,zSuperscripts indicate differences among different levels of dietary protein